Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes

Environmental Science and Pollution Research

Volumn 19, Issue 5, 2012, Pages 1574-1583

  Stasinakis, Athanasios S ^a   Mermigka, Smaragdi ^a   Samaras, Vasilios G ^a   Farmaki, Eleni ^b   Thomaidis, Nikolaos S ^b  

^a UNIVERSITY OF THE AEGEAN   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Emerging contaminants; Risk assessment; Surface waters; Wastewater

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ETHYLENE GLYCOL DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; NONYLPHENOL; PHENOL DERIVATIVE; TERICS; TRICLOSAN;

AQUATIC ORGANISM; CONCENTRATION (COMPOSITION); DRUG; ENDOCRINE DISRUPTOR; ORGANIC COMPOUND; POLLUTANT SOURCE; POLLUTION EFFECT; RISK ASSESSMENT; RIVER POLLUTION; RIVER WATER; SEWAGE TREATMENT; WASTEWATER;

ANIMAL; AQUATIC SPECIES; ARTICLE; CHEMISTRY; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; FISH; GREECE; MASS FRAGMENTOGRAPHY; METHODOLOGY; RISK ASSESSMENT; RIVER; SEWAGE; WATER POLLUTANT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AQUATIC ORGANISMS; ECOTOXICOLOGY; ENDOCRINE DISRUPTORS; ENVIRONMENTAL MONITORING; ETHYLENE GLYCOLS; FISHES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GREECE; PHENOLS; RISK ASSESSMENT; RIVERS; TRICLOSAN; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

GREECE;

ALGAE; DAPHNIIDAE;

EID: 84863190079     PISSN: 09441344     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11356-011-0661-7     Document Type: Article

References (42)

1. Ahel M, Giger W, Koch M (1994) Behaviour of alkylphenol polyethoxylate surfactants in the aquatic environment-I. Occurrence and transformation in sewage treatment. Water Res 28: 1131-1142.
2. Alexander HC, Dill DC, Smith LW, Guiney PD, Dorn P (1988) Bisphenol-A: acute aquatic toxicity. Environ Toxicol Chem 7: 19-26.
3. APHA (1998) Standard methods for the examination of water and wastewater, 20th ed. American Public Health Association, Port City Press, Baltimore, Maryland, USA.
4. Arditsoglou A, Voutsa D (2010) Partitioning of endocrine disrupting compounds in inland waters and wastewaters discharged into the coastal area of Thessaloniki, Northern Greece. Environ Sci Poll Res 17: 529-538.
5. Bendz D, Paxéus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mat 122: 195-204.
6. Birkett JW, Lester JN (2003) Endocrine disrupters in wastewater and sludge treatment processes, CRC Press LLC.
7. o 68-C1-0034.
8. European Union (2001) Decision No 2455/2001/EC of the European Parliament and of the council of 20 November 2001 establishing the list of priority substances in the field of water policy and amending directive 2000/60/EC, Off. J. L331, 15/12/2001.
9. European Union (2003) Technical Guidance Document on Risk Assessment (Part II), European Chemicals Bureau.
10. European Union (2006) Proposal for a Directive of the European Parliament and of the Council on environmental quality standards in the field of water policy and amending Directive 2000/60/EC, 2006/0129, Brussels, 17. 7. 2006.
11. Ferrari B, Mons R, Vollat B, Fraysse B, Paxeus N, Lo Gindice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Tox Chem 23: 1344-1354.
12. Garcia-Galan MJ, Diaz-Cruz MS, Barcelo D (2011) Occurrence of sulfonamide residues along the Ebro river basin: removal in wastewater treatment plants and environmental impact assessment. Environ Int 37: 462-473.
13. Gomez MJ, Martinez Bueno MJ, Lacorte S, Fernandez-Alba AR, Aguera A (2007) Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 66: 993-1002.
14. Gonzalez S, Petrovic M, Barcelo D (2007) Removal of a broad range of surfactants from municipal wastewater-comparison between membrane bioreactor and conventional activated sludge treatment. Chemosphere 67: 335-343.
15. Gros M, Petrovic M, Ginebreda A, Barcelo D (2010) Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 36: 15-26.
16. Halden RU, Paull DH (2005) Co-occurrence of triclocarban and triclosan in U. S. water resources. Environ Sci Technol 39: 1420-1426.
17. Halling-Sorensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lutzhoft HC, Jorgenses SE (1998) Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36: 357-393.
18. Jonkers N, Kohler HPE, Dammshauser A, Giger W (2009) Mass flows of endocrine disruptors in the Glatt River during varying weather conditions. Environ Poll 157: 714-723.
19. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2008) The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42: 3498-3518.
20. Kim Y, Choi K, Jung J, Park S, Kim PG, Park J (2007) Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 33: 370-375.
21. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones and other organic wastewater contaminants in U. S. Streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36: 1202-1211.
22. Kopf W (1997) Wirkung endokriner stoffe in biotests mit wasserogranismen. In Stoffe mit endokriner wirkung in wasser. Bayerisches landesamt fur wasserwitschaft, Institut fur Wasserforschung Munchen (ed) Oldenbourg.
23. Lindberg RH, Bjorklund K, Rendahl P, Johansson MI, Tysklind M, Andersson BAV (2007) Environmental risk assessment of antibiotics in the Swedish environment with emphasis on sewage treatment plants. Water Res 41: 613-619.
24. Loos R, Gawlik BM, Locoro G, Rimaviciute E, Contini S, Bidoglio G (2009) EU-wide survey of polar organic persistent pollutants in European river waters. Environ Pollut 157: 561-568.
25. Möder M, Braun P, Lange F, Schrader S, Lorenz W (2007) Determination of endocrine disrupting compounds and acidic drugs in water by coupling of derivatization, gas chromatography and negative-chemical ionization mass spectrometry. Clean 35: 444-451.
26. Nassef M, Matsumoto S, Seki M, Kang IJ, Moroishi J, Shimasaki Y, Oshima Y (2009) Pharmaceuticals and personal care products toxicity to Japanese medaka fish (Oryzias latipes). J Fac Agr Kyushu U 54: 407-411.
27. Orvos DR, Versteeg DJ, Inauen J, Capdevielle M, Rothenstein A, Cunningham V (2002) Aquatic toxicity of triclosan. Environ Toxicol Chem 21: 1338-1349.
28. Peng X, Yu Y, Tang C, Tan J, Xuang Q, Wang Z (2008) Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Sci Total Environ 397: 158-166.
29. Pomati F, Netting AG, Calamari D, Neilan BA (2004) Effects of erythromycin, tetracycline and ibuprofen on the growth of Synechocystis sp. and Lemna minor. Aquat Toxicol 67: 387-396.
30. Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E (2008) Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci 102: 129-137.
31. Pothitou P, Voutsa D (2008) Endocrine disrupting compounds in municipal and industrial wastewater treatment plants in Northern Greece. Chemosphere 73: 1716-1723.
32. Quinn B, Gagné F, Blaise C (2009) Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuate. Sci Total Environ 407: 1072-1079.
33. Samaras VG, Thomaidis NS, Stasinakis AS, Gatidou G, Lekkas TD (2010) Determination of selected non-steroidal anti-inflammatory drugs in wastewater by gas chromatography-mass spectrometry. Int J Environ Anal Chem 90: 219-229.
34. Samaras VG, Thomaidis NS, Stasinakis AS, Lekkas TD (2011) An analytical method for the simultaneous trace determination of acidic pharmaceuticals and phenolic endocrine disrupting chemicals in wastewater and sewage sludge by gas chromatography-mass spectrometry. Anal Bioanal Chem 399: 2549-2561.
35. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144: 383-395.
36. Singer H, Muller S, Tixier C, Pillonel L (2002) Triclosan: occurrence and fate of a widely used biocide in the aquatic environment: field measurements in wastewater treatment plants, surface waters, and lake sediments. Environ Sci Technol 36: 4998-5004.
37. Staples CA, Dorn PB, Klecka GM, O'Block ST, Haris LR (1998) A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere 36: 2149-2173.
38. Stasinakis AS, Gatidou G, Mamais D, Thomaidis NS, Lekkas TD (2008) Occurrence and fate of endocrine disrupters in Greek sewage treatment plants. Water Res 42: 1796-1804.
39. Stephenson RR (1983) Diphenylol propane: acute toxicity to Daphna magna and Selenastrum capricornutum. Shell group research report SBGR. 83. 216.
40. Yoon Y, Ryu J, Oh J, Choi BG, Snyder SA (2010) Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci Total Environ 408: 636-643.
41. Zhang Y, Geiben SU, Gal C (2008) Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73: 1151-1161.
42. Zhou JL, Zhang ZL, Banks E, Grover E, Jiang JK (2009) Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J Haz Mater 166: 655-661.